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ABSTRACT
The recent publication of fetal growth and gestational age–specific growth standards by the International Fetal and Newborn Growth
Consortium for the 21st Century Project and the previous publication by the WHO of infant and young child growth standards based on the
WHO Multicentre Growth Reference Study enable evaluations of growth from ;9 wk gestation to 5 y. The most important features of these
projects are the prescriptive approach used for subject selection and the rigorous testing of the assertion that growth is very similar among
geographically and ethnically diverse nonisolated populations when health, nutrition, and other care needs are met and the environment
imposes minimal constraints on growth. Both studies documented that with adequate controls, the principal source of variability in growth
during gestation and early childhood resides among individuals. Study sites contributed much less to observed variability. The agreement
between anthropometric measurements common to both studies also is noteworthy. Jointly, these studies provide for the first time, to my
knowledge, a conceptually consistent basis for worldwide and localized assessments and comparisons of growth performance in early life. This is
an important contribution to improving the health care of children across key periods of growth and development, especially given the
appropriate interest in pursuing “optimal” health in the “first 1000 d,” i.e., the period covering fertilization/implantation, gestation, and postnatal
life to 2 y of age. Adv Nutr 2015;6:383–90.
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Introduction
The recent publication of fetal growth and gestational age–
specific birth weight, length, and head circumference stan-
dards by the International Fetal and Newborn Growth
Consortium for the 21st Century (INTERGROWTH-
21st)3 Project and the previous publication by the WHO
of infant and young child growth standards (the WHOChild
Growth Standards) based on the WHO Multicentre Growth
Reference Study (MGRS) enable growth monitoring from
early pregnancy (;9 wk) through 5 y of age (1–6). Similar-
ities between the 2 studies’ prescriptive approaches, designs,
and international sampling frames provide for the first time,
to my knowledge, a conceptually consistent basis for world-
wide and localized assessments and comparisons of growth
performance in early life. These are important contributions
to improve health care by harmonizing common criteria
used in health screening, growth monitoring, and assessing
the effectiveness of interventions designed to improve health
across key periods of growth and development.
Two ongoing dynamics make the new standards particu-
larly relevant to contemporary health policies and practices.
These relate to a steadily improving understanding of the
significance of health in preceding life stages to subsequent
well-being and the growing robustness of assertions that
health is a prerequisite for economic development, not
just an important benefit that accompanies its attainment.
The former has brought steadily greater interest in pursuing
1 The author reports no funding received for this study. This is a free access article, distributed
under terms (http://www.nutrition.org/publications/guidelines-and-policies/license/) that
permit unrestricted noncommercial use, distribution, and reproduction in any medium,
provided the original work is properly cited.
2 Author disclosures: C Garza, no conflicts of interest.
* To whom correspondence should be addressed. E-mail: bert.garza@bc.edu.
3 Abbreviations used: BL, birth length; CRL, crown-rump length; FHC, fetal head
circumference; GWAS, genome-wide association study; INTERGROWTH-21st, International
Fetal and Newborn Growth Consortium for the 21st Century; MGRS, Multicentre Growth
Reference Study; SSD, standardized size difference.































“optimal” health in the “first 1000 d,” i.e., the period cover-
ing fertilization/implantation and gestation through the
postnatal age of 2 y (7). The second brings increasing ur-
gency to the view that investments of human and financial
resources to improve health yield substantial short- and
long-term returns, rather than only costs unlikely to result
in broad, realized gains (8, 9). Nonetheless, some correctly
caution against uncritically linking anthropometric data to
living standards (10).
The 2 most important features of the INTERGROWTH-
21st Project and MGRS are, first, that both were based on a
prescriptive approach that broadened the definition of
health beyond an-absence-of-disease criterion to include
the adoption of recommended health practices and behav-
iors, parental education, and socioeconomic and environ-
mental factors of significance to short- and long-term
health (11, 12) and, second, that both rigorously tested the
assertion that growth is very similar among geographically
and ethnically diverse nonisolated populations when health,
nutrition, and other care needs are met, and the environ-
ment imposes minimal constraints on growth. In effect,
rather than describe how children grew at particular
times and places, the INTERGROWTH-21st Project and
the MGRS collected data describing how fetuses/children
should grow regardless of time and place, supporting a
healthy start for all children. This article provides a brief sum-
mary of the INTERGROWTH-21st Project and the MGRS,
identifies examples of policies supported by the results of
both studies, and suggests selected research opportunities
that arise from the findings of the 2 studies.
Design and Methods
The INTERGROWTH-21st Project included 3 studies con-
ducted at 8 sites: Brazil, China, India, Italy, Kenya, Oman,
the United Kingdom, and the United States. These studies
included 1) a cross-sectional component (n = 59,137
women of whom 20,486 gave birth to eligible newborns) de-
signed for the purpose of constructing newborn standards;
2) a longitudinal fetal growth component conducted in a co-
hort of healthy women (n = 4607) in whom fetal growth was
monitored with ultrasound scans every 4–6 wk from 9 to
14 wk of gestation to birth and their progeny were followed
to age 2 y to assess health, growth, and neurodevelopment;
and 3) a postnatal longitudinal growth component that closely
monitored infants in the longitudinal cohort who were
born prematurely. In total, nearly 60,000 women, children,
and their families participated in the project’s 3 components
(13).
The MGRS obtained data on growth trajectories from
birth to 5 y in children enrolled from 6 sites in Brazil,
Ghana, India, Norway, Oman, and the United States (14).
It included 2 components, a longitudinal one (n = 1743)
from 0 to 24 mo (that included 21 home visits) and a
cross-sectional (n = 6697) one that included children aged
18–71 mo (15). In applying a prescriptive approach, both
studies operationalized definitions for “optimal” nutrition,
environments, and care with the goal of defining “optimal”
growth, within the constraints of studies conducted in
community-based settings.
Similarities between the 2 studies extended beyond a
common prescriptive approach and their international
reach. Other similarities were their community-based
designs that avoided biases such as those likely to emerge
from hospital-based sampling frames and extensive, real-
time quality controls that contributed importantly to the
high quality of their data. Those controls included the
provision of uniform equipment across sites, strict standard-
ization including training of research staff and multiple-
blinded observer protocols for all key measurements, and
regularly scheduled assessments of adherence to standard-
ized procedures, regular testing of the standardized equip-
ment’s functionality, and real-time monitoring of collected
data for accuracy, precision, and integrity. These were
described in detail in previous publications (13, 16).
Individual and site eligibility criteria used by the INTER-
GROWTH-21st Project and the MGRS were similar. Criteria
in both studies were selected with the goal of identifying
healthy populations seemingly free of disease, following cur-
rent health recommendations, and living in environments
unlikely to constrain growth. The specific contexts of
healthy conditions, however, necessarily differed among
study sites because individuals from very diverse countries
were enrolled, e.g., India, Italy, Kenya, and Norway, but all
contexts shared at least one common feature, i.e., each was
assessed to be nongrowth constraining. Environmental cri-
teria were of special concern to the INTERGROWTH-21st
Project. The absence or sufficiently low levels of nonmicro-
biological environmental contaminants that could adversely
affect maternal and fetal health was documented for each
candidate site, e.g., domestic smoke, unacceptable exposures
to pollution, and/or radiation (17).
Some site, environmental, and population characteristics
were controlled across all sites, e.g., altitude because of its
documented impact on fetal and postnatal growth (18,
19). The INTERGROWTH-21st Project set its altitude limit
at 1600 m in order to include a sub-Saharan malaria-free re-
gion (the Parkland area in Nairobi, Kenya); similarly, the
MGRS limited its study populations to those living at
<1500 m. The longitudinal aspects of both studies required
low mobility populations. Site eligibility in the INTER-
GROWTH-21st Project was limited to urban communities
where at least 80% of prenatal care and deliveries occurred
within a manageable number of institutions. A similar crite-
rion was used by the MGRS. The institutions, in turn, were
judged to have the human and physical resources necessary
to meet the 2 studies’ requirements. For individuals enrolled
in the INTERGROWTH-21st Project, eligibility was re-
stricted to those with no obstetric and/or gynecologic or
other health histories and conditions likely to affect preg-
nancy adversely, those who initiated antenatal care before
14 wk gestation, and those who met other criteria consistent
with good nutrition, health, and socioeconomic circum-
stances. Additionally, only singleton pregnancies achieved
































individual eligibility criteria have been published previously
(13, 14, 20–25).
For the MGRS, in addition to the documentation of nor-
mal pregnancies, feeding criteria were particularly relevant
in that enrollment was limited to women willing to try
breastfeeding exclusively or predominantly for 4–6 mo
with continued breastfeeding for at least 1 year. Nearly
75% of infants were exclusively or predominantly breastfed
for at least 4 mo, 99.5% were started on complementary
foods by 6 mo, and 68.3% were partially breastfed until at
least 12 mo (26). Only children who were breastfed exclu-
sively or predominantly for at least 4 mo with complemen-
tary feeding introduced by 6 mo and who continued
breastfeeding for at least 1 y were included in the construc-
tion of the WHO standards. That success was due to, in large
part, the selection of sites with existing breastfeeding sup-
port systems that the MGRS could strengthen (26). Other
eligibility criteria were applied by the MGRS to avoid
growth-constraining conditions. For example, only infants
of women who did not smoke before or after delivery
were included; as for the children, only singletons and those
born at term and free of any noteworthy morbidity at birth
were enrolled.
Results
Results published by the INTERGROWTH-21st Project and
MGRS are remarkably consistent notwithstanding the mul-
tiple year separation between the 2 studies’ data collection
phases (1, 2, 6, 14, 27). Table 1 summarizes the standards
that have been published by the INTERGROWTH-21st Pro-
ject and the MGRS. The results that undergird those tools
are of substantial importance to public health and clinical
management. Of most interest are the 1) similarities in
growth among geographically and ethnically diverse noniso-
lated populations enrolled by both studies notwithstanding
intersite differences in parental anthropometry, 2) agree-
ment between anthropometric measurements common to
both studies at birth and 2 y, and 3) the high quality of
the population-based, large data sets.
The INTERGROWTH-21st Project and MGRS applied 3
approaches jointly to assess the appropriateness of pooling
growth data for the purpose of developing anthropometric
standards: 1) estimating the relative contributions of inter-
site and interindividual variation to the total observed vari-
ation; 2) estimating differences between a site’s mean
anthropometric measures and the corresponding “all-site”
means relative to the corresponding “all site” SDs, i.e., “stan-
dardized size differences” (SSDs); and 3) sensitivity analyses
that assessed the impact of deleting individual sites on the
remaining data’s central tendencies (50th percentile) and
values at the 3rd and 97th percentiles. For these purposes,
both studies used measures of skeletal growth most likely
to be normally distributed; i.e., crown-rump length (CRL;
<14 wk gestation), fetal head circumference (FHC; 14–42
wk), and birth length (BL) were examined by the INTER-
GROWTH-21st Project and length from birth to 2 y was
used by the MGRS (1,19–20). These were selected as the
anthropometric characteristics least likely to be affected by
recent trends related to overweight and obesity and, thus,
the measures most reflective of inherent growth potentials.
The INTERGROWTH-21st Project found that 1.9%,
2.6%, and 3.5% of the total variability in CRL, FHC, and
BL, respectively, were attributable to intersite differences.
The contribution of interindividual differences in FHC to
the total observed variation was 7-fold higher, i.e., ~19%
of the total (27). Similar estimations were not made for CRL
and BL because they were only measured cross-sectionally.
The proportion of total variability in length attributable
TABLE 1 Anthropometric standards published by the





CRL Papageorghiou et al. (1)
Attained fetal growth
(14 wk to birth)
Head circumference for
gestational age
Papageorghiou et al. (6)
Biparietal diameter for
gestational age
Papageorghiou et al. (6)
Occipital parietal diameter for
gestational age
Papageorghiou et al. (6)
Femur length for gestational
age
Papageorghiou et al. (6)
Abdominal circumference for
gestational age
Papageorghiou et al. (6)
Attained growth at birth
Weight for gestational age
at birth
Villar et al. (2)
Length for gestational age
at birth
Villar et al. (2)
Head circumference for
gestational age at birth
Villar et al. (2)
Attained postnatal growth
Weight for age Department of Nutrition for Health
and Development, WHO (3)
Length/height for age Department of Nutrition for Health
and Development, WHO (3)
Weight-for-length/height Department of Nutrition for Health
and Development, WHO (3)
BMI for age Department of Nutrition for Health
and Development, WHO (3)
Midupper arm circumference
for age
Department of Nutrition for Health
and Development, WHO (4)
Triceps skinfold for age Department of Nutrition for Health
and Development, WHO (4)
Subscapular skinfold for age Department of Nutrition for Health
and Development, WHO (4)
Head circumference for age Department of Nutrition for Health
and Development, WHO (4)
Postnatal growth velocity
Weight Department of Nutrition for Health
and Development, WHO (5)
Length/height Department of Nutrition for Health
and Development, WHO (5)
Head circumference Department of Nutrition for Health
and Development, WHO (5)
1 CRL, crown-rump length; INTERGROWTH-21st Project, International Fetal and new-
born Growth Consortium for the 21st Century; MGRS, Multicentre Growth Reference
Study.































to intersite differences in the MGRS was 3.4%, a value sim-
ilar to those reported by the INTERGROWTH-21st Project.
The proportion of total variability attributable to interindi-
vidual differences in the MGRS was 70%, or ~20 times the
contribution of intersite differences (28). These findings
are consistent with growth/stature being a complex quanti-
tative genetic trait (29–31).
Both studies applied a cutoff of #0.5 for estimates of
SSDs to pool data. This was considered a conservative cutoff
because it is based on SDs derived from means of 3 highly
standardized measures of the same subject at each study
visit. That protocol resulted in relatively small SDs unlikely
to be achieved in less-controlled settings/protocols. The low
SDs, in turn, increased SSD estimates. One hundred twenty-
eight SSDs were calculated for specified gestational age
windows by the INTERGROWTH-21st Project in its exam-
ination of intersite heterogeneity/homogeneity. Only 1 of
the 128 values was >0.5, i.e., 0.58. The MGRS made 54 anal-
ogous estimates for age-specific comparisons of length
(birth to 2 y) and stature (2–5 y). None exceeded 0.5.
The results of sensitivity analyses were similarly consistent
between the 2 studies. Impacts on the overall 3rd, 50th, and
97th percentile values after sequentially eliminating any
one individual site’s values were minimal in both the
INTERGROWTH-21st Project and the MGRS. The results of
these 3 approaches for assessing the heterogeneity/homogeneity
of the sites’ growth characteristics strongly support the univer-
sality of growth characteristics of nonisolated populations
whose living conditions do not constrain growth.
The agreement between anthropometric measurements
common to both studies also is noteworthy. Mean BL for
the longitudinal and cross-sectional components of the
INTERGROWTH-21st Project were strikingly similar, 49.4 6
1.9 cm (mean 6 SD) and 49.5 6 1.9 cm, respectively, con-
firming the representativeness of the longitudinal sample,
and even more striking was their similarity to that of the
MGRS’ corresponding value, 49.5 6 1.9 cm. The birth
weights for the INTERGROWTH-21st Project and MGRS
also were strikingly similar, 3.3 6 0.4 kg and 3.3 6 0.5 kg
for the former’s longitudinal and cross-sectional compo-
nents, respectively, and 3.3 6 0.5 kg for the MGRS. Length
and head circumference measurements for boys and girls
at 1 y of age in the INTERGROWTH-21st Project corre-
sponded to the MGRS’ 49th and 52nd percentiles and
49th and 50th percentiles, respectively.
Examples of the resulting MGRS and INTERGROWTH-
21st Project anthropometric data are found in Figures 1 and
2. Figure 1 illustrates smoothed curves for BL of infant girls
and boys born at 33–43 wk gestation, respectively, and over-
lapping empirical values in the INTERGROWTH-21st Pro-
ject. Figure 2 illustrates smoothed curves for the 3rd, 50th,
and 97th percentiles for length from birth to 2 y of age
with overlapping empirical values in the MGRS.
Discussion
Results of the INTERGROWTH-21st Project and MGRS, in-
cluding similarities among study sites and agreement between
the 2 studies, underscore the universality of the potential of
physical growth from early gestation to at least 5 y of age in
nonisolated, healthy human populations. Those findings
were not unexpected given earlier work published by Habicht
et al. (32) and others (33, 34). They also are consistent with
knowledge regarding the genetic control of stature, the genetic
underpinnings of complex quantitative traits, and anthropo-
logic investigations of human migrations (29–31).
Beyond the findings’ conceptual importance, results from
both studies provide a common international norm for early
growth that is most consistent with a healthy start for all
children and provide tools for applying those norms to
both populations and individuals. Continuity of antenatal
and postnatal care, using the same conceptual instruments
from <9 wk of pregnancy (including pregnancy dating) to
the neonatal period and beyond, harmonized across countries
FIGURE 1 Fitted 3rd, 50th, and 97th smoothed percentile
curves (dashed blue lines) for BL according to gestational age
showing empirical values for each week of gestation (open red
circles) and the actual observations (closed gray circles). (A) Girls;

































is a major step forward to improve quality of care in ma-
ternal and child health. The ease of use, relevance, and
need for such tools was affirmed by the rapid global adop-
tion of the WHO international growth standards (based on
the findings of the MGRS) by >125 countries within 6 y of
their release (35). A similar global acceptance and wide im-
plementation are expected for the standards resulting from
the INTERGROWTH-21st Project.
Affirming the universality of human physical growth po-
tential and the availability of its operational counterpart, the
first international “prescriptive” growth standards are par-
ticularly timely. Cumulative evidence supports that well-
being in preceding life stages is key to maximizing health
in subsequent periods and that early life stages have the
most profound effect of all on health. This increasing aware-
ness has led to a steadily growing interest in optimizing
health in the first 1000 d (7, 36, 37). Arguably, the most
evocative illustration of this perspective is the hypothesis
proposed by Barker (36) ~20 y ago. The “early origins of
adult disease” hypothesis is countered often by arguments
that point to “continuity of circumstances” as alternative ex-
planations for lifelong and transgenerational impacts of
early life stages on adult chronic diseases (38, 39). On the other
hand, animal studies have countered such arguments and
explored mechanisms responsible for links between early
health and adult disease and transgenerational effects of
early life experiences (40, 41).
The 2 international sets of growth standards are appropri-
ate for use in populations and individuals. That wide range of
applications to health care is enabled by 2 key characteristics of
growth. The first applies to growth generally and the second is
a consequence of the high velocity of growth in early life stages.
First, “much must go right” for growth to proceed normally at
individual and population levels. This characteristic is partic-
ularly useful for screening purposes because growth is sensitive
to a wide range of influences but is seldom diagnostic. Second,
the high velocity of early growth enables relatively rapid
evaluations of interventions and/or changing conditions (42).
In an extensive study that led to the MGRS and INTER-
GROWTH-21st Project, the WHO reviewed the “signifi-
cance of anthropometric indicators and indices.(provided)
guidance on the use and interpretation of anthropometric
measures (in various life stages).(and outlined) specific ap-
plications of anthropometry in individuals and populations
for purposes of screening for targeting and evaluating inter-
ventions” (42). Importantly, theMGRS’s and INTERGROWTH-
21st Project’s community-based sampling frames, the
inclusion of communities from diverse global regions, and
the common prescriptive approach based on social and envi-
ronmental conditions, in addition to an absence-of-disease
criterion, also provide realistic targets for normalizing growth
locally and globally.
There also are other pragmatic considerations that merit
attention. The selection of references or standards matters to
decision-making. Conflicting inferences derived from the
application of the previous international growth reference
for young children, the CDC 2000, the current WHO stan-
dards for infants and young children, and various fetal
biometry references have been examined recently. These in-
vestigations illustrated disparate conclusions that resulted
from their application to the same data, e.g., in assessments
of breastfeeding adequacy (43), determination of rates of
stunting (43, 44), rates of biparietal diameters below the fifth
percentile (45), diagnosis of excess weight gain (43, 46), and
assessments of mortality risk (47).
It is too early to assess whether standards derived from
the INTERGROWTH-21st Project will be adopted as widely
as those derived from the MGRS; the WHO standards have
undergone close scrutiny and have been adopted by >125
countries. Nonetheless, the previous lack of fetal, neonatal,
and preterm postnatal growth standards based on the
same populations analogous to the WHO’s postnatal stan-
dards was viewed as problematic. The lack of international
standards led to reliance on multiple references, each
describing fetal growth in specific settings (mostly hospital
based) and times and without the advantages of common
FIGURE 2 Mean length from birth
through 2 y illustrated as smoothed
percentile curves and corresponding
empirical observations. P3, 3rd percentile;
P10, 10th percentile; P50, 50th percentile;
P90, 90th percentile; P97, 97th percentile.
Reproduced from reference 3 with
permission.































standardization protocols. This has led, unnecessarily, to com-
plications of various types, e.g., disparate interpretation of
prevalence rates of small-for-gestational-age infants, and dis-
parities in attributing country- or region-specific morbidity
and mortality to that condition (1, 13, 48). The INTER-
GROWTH-21st Project offers solutions to those shortcomings.
The INTERGROWTH-21st Project’s gestational-age–
specific newborn standards, its strict protocol for determin-
ing gestational age, and the availability of cross-sectional and
longitudinal data for term and preterm infants across its
diverse sites enable substantial improvements in regional
and global prevalence estimates of diverse outcomes. They
also provide relevant research opportunities, e.g., more
robust explorations of relations among specific growth tra-
jectories, attained growth characteristics, maternal charac-
teristics, specific fetal and newborn outcomes, and specific
phenotypes of prematurity. Each of them, in turn, represents
prospects to better assess therapeutic responses of infants
born small for gestational age or prematurely and to better
understand maternal conditions that adversely affect the
developing fetus (37, 49–52).
Notwithstanding the WHO standards’ initial successes
and growing interest worldwide in the INTERGROWTH-
21st Project’s early publications, 2 concerns are commonly
expressed regarding the published international standards.
These relate to the genetic dimensions of growth and to
the relevance of prescriptive-based standards to populations
that experience high rates of stunting.
The first common question is formulated as follows,
“How is the observed similarity in growth possible given
the enrolled populations’ perceived diverse genetic back-
grounds, e.g., Norway and India?” The genetic regulation
of growth is well documented: clearly, tall parents tend to
have tall children and short parents tend to have short chil-
dren. That common observation, however, is the conse-
quence of interindividual genetic differences, and it is
valid within both the Norwegian and the Indian popula-
tions, rather than interpopulation genetic variation. Indeed,
genome-wide association studies (GWASs) have found ~200
genes associated with stature (31). Those genes collectively
explain ;10% of observed variability in the stature of the
GWAS’ populations. That small proportion of explained
variation in stature likely reflects difficulties of detecting
genes with yet weaker individual effects and/or the limited
attention given, to date, to possible roles of other regulatory
mechanisms, e.g., those based on structural variation and
epistasis (53, 54). The low proportion of variation explained
by GWAS also may reflect unaccounted-for differences in
nutrition, care, and environmental conditions experienced
by subjects enrolled in GWAS studies. The magnitude of
this proportion is in agreement with the low percentage of
the total variation attributable to interpopulation variance
observed by the MGRS and the International Fetal and New-
born Growth Consortium projects in which any of the afore-
mentioned conditions were standardized.
The second common question is related to the appropri-
ateness of using prescriptive-based standards in historically
undernourished populations. This, in turn, stems from at
least 2 concerns. One relates to possible adverse effects on
adult health of promoting rapid growth in early life in those
populations and the other to possible transgenerational con-
straints on growth in children of parents or possibly even
grandparents who were undernourished as children (55,
56). Several reports support the possibility that rapid weight
gain in early life leads to a higher risk of childhood obesity
and chronic diseases of adult onset, but that failing to redress
anthropometric shortcoming in early life may impede cogni-
tive development (49, 57–59). Simultaneous changes in stat-
ure often are omitted in such analyses. On the other hand,
there are data suggesting that rapid simultaneous and propor-
tional gains in weight and stature do not present similar risks
(60). Furthermore, I am unaware of any data suggesting that
catch-up growth characterized by proportional gains in
length and weight results in increased risk to either childhood
obesity or chronic diseases of adult onset.
Colleagues and I (61) recently examined limited aspects
of the second concern related to putative transgenerational
constraints on growth in children of parents who were un-
dernourished in childhood. That investigation compared
the MGRS children’s predicted adult heights with the aver-
age of their parents’ heights. The children’s predicted adult
height was estimated by doubling the children’s length mea-
sured at 2 y of age (with corrections for the conversion of
lengths to heights). We predicted no differences would be
observed between the children’s estimated adult heights
and the corresponding mid–parental heights for the Norwe-
gian and United States sites but significant differences in the
children’s favor in the remaining 4 sites, i.e., in the sites more
likely to include parents who were less adequately nourished
as children: Brazil, Ghana, India, and Oman. The findings
matched our predictions (Figure 3). The vertical axis shown
in Figure 3 summarizes site-specific differences between the
children’s predicted adult heights and the mean heights of
FIGURE 3 Means (points) and SDs (bars) of the difference
between 2 times the height of the child at 2 y and the mid–

































the children’s mothers and fathers. As predicted, differences
for Norway and the United States were zero but significantly
positive in the remaining 4 sites. The substantial similarities
in the children’s length across all sites at all ages examined
were consistent with the conclusion that the children’s adult
heights also will be similar. These findings support the ex-
pectation that stature can be normalized in one generation,
at least in populations with degrees of parental short stature
that are similar to those of communities enrolled in the
MGRS. They also reinforce the likelihood that secular trends
in growth reflect, in part, rates at which health and eco-
nomic progress permeate impoverished populations rather
than unavoidable biological constraints.
In conclusion, the INTERGROWTH-21st Project and
MGRS present the world with clear norms that are based
on what can be achieved in communities when growth needs
are met. The community-based approach to sampling and
the international framework used by the 2 studies support
the view that their findings describe achievable goals that
are within biological reach. The caveat is that needs for nor-
mal growth must be met from early gestation through at
least 5 y of age. Additionally, it is important to recognize
that normalized growth is not sufficient to assure desired
levels of health and development. It is, nonetheless, a neces-
sary and important goal given the short- and long-term con-
sequences of constrained growth imposed by poor nutrition,
environments, and/or care. “Universal norms” for assessing
stature and other anthropometric characteristics, similar to
most other areas of medicine, are now available, and holding
ourselves accountable for attaining them is the responsible
choice available to the global health community.
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